Will there be a national screening program for colorectal cancer?

There are ongoing discussions about whether to implement a national screening program for colorectal cancer in Norway. Prof. Bretthauer has contributed in a summary of the current evidence base regarding health effects of this type of screening. A decision is expected this fall.

POLE proofreading domain mutations identify a subset of immunogenic colorectal cancers with excellent prognosis

A multicentre biomarker study, including data from the research teams of professors Ragnhild A. Lothe and Arild Nesbakken at the K.G. Jebsen Colorectal Cancer Research Centre, OUH, was recently published in Lancet Gastroenterology & Hepatology.

Latest publications

García-Albéniz X et al. 2016. Effectiveness of Screening Colonoscopy to Prevent Colorectal Cancer Among Medicare Beneficiaries Aged 70 to 79 Years: A Prospective Observational Study. Ann Intern Med. 2016 Sep 27. [Epub ahead of print]. Domingo E et al. 2016. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study. The Lancet Gastroenterology & Hepatology. Available online 20 July 2016. Sveen A et al. 2016. Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver Resection. PLoS Genet. 2016 Jul 29;12(7):e1006225. Cameron MG et al. 2016. Palliative pelvic radiotherapy for symptomatic rectal cancer – a prospective multicenter study. Acta Oncol. 2016 Jun 22:1-8. Rønning B et al. 2016. Quality of life in older and frail patients after surgery for colorectal cancer – A follow-up study. J Geriatr Oncol. 2016 May;7(3):195-200. All publications